Products & SolutionsWho We ServeCase StudiesContact Us
Login
Search Articles

Canadian Firm Makes U.S. Biotech Debut With New San Diego Office

Entos Pharmaceuticals Looks To Double Footprint in Tight Torrey Pines Enclave
Entos Pharmaceuticals has opened research and development operations in San Diego's Torrey Pines neighborhood, with plans to add a nearby manufacturing facility later this year. (Jeff Thomas/Vertex Photography)
Entos Pharmaceuticals has opened research and development operations in San Diego's Torrey Pines neighborhood, with plans to add a nearby manufacturing facility later this year. (Jeff Thomas/Vertex Photography)
CoStar News
June 8, 2022 | 12:26 AM

RELATED ARTICLES

Canada’s Entos Pharmaceuticals has established its first beachhead in the U.S., taking space in San Diego with plans to more than double its local workforce and real estate footprint in the coming 18 months as demand for life science space in the region remains strong.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Explore CoStar

Already A Subscriber? Sign In

Follow us on Social Media

IN THIS ARTICLE

News | Canadian Firm Makes U.S. Biotech Debut With New San Diego Office